[Skip to content]

tab rollover pre-load tab rollover pre-load tab rollover pre-load tab rollover pre-load tab rollover pre-load tab rollover pre-load
Monday 27 September 2021
Salford GP Header Montage
Latest News:
RSS icon
Search
.
Medicine, tablets, pills

Formulary

This is an electronic version of our Formulary written in conjunction with the Medicine Management Committee and the Pharmacy department.   The purpose of the Formulary is:

  • To promote safe, rational and cost effective prescribing within the Trust.
  • To help select the most appropriate drug amongst the many available.

 

This formulary is intended to act as a rapid reference source.  It is intended for the guidance of medical practitioners, nurses and other healthcare workers.

 

For local GPs and Non-medical prescribers working in the community there is the Greater Manchester Joint Formulary produced by the Greater Manchester Medicines Management Group (GMMMG).  The formulary ensures that patients receive seamless care across the primary-secondary care interface and reduces the need for switching programmes. All medicines recommended for use in the NHS in a NICE Technology Assessment (TA) are approved for use in Greater Manchester, the GMMMG site provides a list of medicines with a positive recommendation from  NICE and provides links to these TAs in the GMMMG formulary.  In the SRFT formulary below all the drugs with a positive NICE TA that are applicable to SRFT are included in the formulary.

 

How to use

All medicines are listed alphabetically using the generic name where possible.  Some brand names are used.

 

  1. Type the drug name in the 'Keywords' box

  2. Click on the 'Search' button

  3. Within the results, click on the 'generic name' of the medicine you are looking for.

  4. Click on the 'Link' - this will take you to further information that talks about that medicine. 

 

 

Drug NameBNF CategoryComment / Usage RestrictionsDetails
Ibandronate IV (Bonviva)6.6.2 BisphosphonatesFor use by consultant rheumatologists in the treatment of post-menopausal osteoporosis only 
Ibrutinib See online BNFIbrutinib is proposed for use for the treatment of relapsed/refractory Chronic Lymphocytic  Leukaemia or treatment of relapsed/refractory Mantle Cell Lymphoma when conditions specified within the formulary application are met.  Approved April 2015 for initiation by Consultant Haematologists in line with CDF funding. Consultants must ensure that the patient is registered on the CDF tracker before initiating.   
Ibuprofen10.1.1 Non-steroidal anti-inflammatory drugs  
Icatibant - Injection 10mg/ml3.4.3 Allergic emergenciesAcute attacks of hereditary angioedema in patients with C1-esterase inhibitor deficiency Approved at MMG Nov 2009 Use by immunology only  
Ichthopaste Bandage13.5.1 Preparations for eczemaDermatology only 
IdelalisibSee online BNFIdelalisib is proposed for the treatment of relapsed/refractory Chronic Lymphocytic Leukaemia when the conditions specified within the formulary application are met.  Approved April 2015 for initiation by Consultant Haematologists in line with CDF funding. Consultants must ensure that the patient is registered on the CDF tracker before initiating.   
IdelalisibSee online BNFIdelalisib (Zydelig), given with a drug called rituximab, is recommended as a possible treatment for adults with: • Untreated chronic lymphocytic leukaemia, only if they have certain genetic characteristics • Chronic lymphocytic leukaemia, only if it has been treated but has come back within 2 years. Approved February 2016as per NICE TA 359  
Iloprost2.5.1 VasodilatorsRheumatology only 
Imatinib8.1.5 Other antineoplastic drugsIn accordance with NICE guidance. Haematology only, CML June 2017 MMG update - North West’s contracted generic imatinib (Wockhardt) – has now been granted a license for adult chronic CML. This applies to PL 29831/0638 (100mg tablets) and PL 29831/0639 (400mg tablets) This license extension does NOT cover gastrointestinal stromal tumours (GIST), for which the Novartis product (Glivec®) still has an active patent.  
Imipenem5.1.2.3 Other beta-lactam antibiotics  

 

All material in this section is aimed at health professionals, but is information currently held within the public domain.   Members of the public seeking advice on medicine-related matters are encouraged to speak with their GP, pharmacist or nurse, or contact NHS Direct on 0845 46 47.